Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Complicaciones y tratamiento
Información de la revista
Vol. 1. Núm. 2.
Páginas 67-70 (Enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 2.
Páginas 67-70 (Enero 2003)
DOI: 10.1016/S1696-2818(03)71591-1
Acceso a texto completo
Complicaciones y tratamiento
Visitas
...
Lourdes Román, Adolf Valls
Unidad Neonatal. Departamento de Pediatría. Universidad del País Vasco/E.H.U. Hospital de Cruces. Barakaldo. Bizkaia. España.
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.J. Martín.
Neonatal surfactant therapy Where do we go?.
J Pediatrics, 118 (1991), pp. 555
[2.]
H.L. Halliday.
Surfactant replacement.
Year Book of Neonatal Medicine 1991, pp. XIV-XXI
[3.]
R.F. Soll, et al.
Natural surfactant extract treatment of RDS.
Neonatal Module of the Cochrane Database of Systematic Reviews. The Cochrane Collaboration, Issue 1,
[4.]
R.F. Soll, F. Blanco.
Natural surfactant extract vs. synthetic surfactant in the treatment of established respiratory distress syndrome.
Systematic Review, Issue 1,
[5.]
H.L. Halliday.
Overview of clinical trials, comparing natural and synthetic surfactants.
Biol Neonate, 67 (1995), pp. 32.ECC
[6.]
R.F. Soll, C.J. Morley, v.s. Prophylactic.
selective use of surfactant in preventing morbidity and mortality in preterm infants.
Systematic Review, Issue 1,
[7.]
J. Egberts, R. Brand, H. Walti, G. Bevilacqua, G. Breart, F. Gardini.
Mortality, severe respiratory distress syndrome and chronic lung disease of newborn are reduced more after prophylactic than after therapeutic administration of surfactant curosurf.
Pediatrics, 100 (1997), pp. E4
[8.]
R.F. Soll.
Surfactant treatment of the very preterm infant.
Biol Neonate, 74 (1998), pp. 35-42
[9.]
Valls i Soler A, Fernández-Ruanova B, López-Heredia y Goya J, Román- Etxebarria L, Rodríguez-Soriano J, Carretero V. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group. Pediatrics 1998; 101:E4. Disponible en http://www.pediatrics.org/cgi/content/full/101/4/e ECC
[10.]
E.M. Zola, J.H. Gunkel, R.K. Chan, M.O. Lim, I. Knox, B.H. Feldman, et al.
Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome.
J Pediatr, 122 (1993), pp. 453-459
[11.]
T.N. Raju, P. Langenberg.
Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis.
J Pediatr, 123 (1993), pp. 603-610
[12.]
P.B. Pandit, M.S. Dunn, E.A. Colucci.
Surfactant therapy in neonates with respiratory deterioration due to pulmonary haemorrhage.
Pediatrics, 95 (1995), pp. 32-36
[13.]
W.F. Walsh, T.A. Hazinski.
Bronchopulmonary dysplasia.
Intensive Care of the Fetus and Neonate, pp. 642
[14.]
A.R. McPherson.
Retinopathy of Prematurity,
[15.]
G.A. Gregory, J.A. Kitterman, R.H. Phibbs, W.H. Tooley, W.K. Halmilton.
Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure.
N Engl J Med, 284 (1971), pp. 1333-1340
[16.]
R.A. Saunders, A.D. Milner, I.E. Hopkin.
The effect of CPAP on lung mechanics and lung volumes in the neonate.
Biol Neonate, 29 (1976), pp. 178-186
[17.]
M.K. Gittermann, C. Fusch, A.R. Gittermann, B.M. Regazzoni, A.C. Moessinger.
Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infant.
Eur J Pediatr, 156 (1997), pp. 384-388
[18.]
P. Subramanian, D.J. Henderson-Smart, P.G. David.
Prophylactic nasal continuos positive airways pressure for preventing morbidity and mortality in very preterm infants.
Systematic Review, Issue 1,
[19.]
V. Kavvadia, A. Greenough, G. Dimitriou.
Effect on lung function of continuous positive airway pressure administered either by infant flow driver or a single nasal prong.
Eur J Pediatr, 159 (2000), pp. 289-292
[20.]
H. Verder, B. Robertson, G. Greisen, F. Ebbesen, P. Albertsen, K. Lundstrom, et al.
Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome.
N Engl J Med, 331 (1994), pp. 1051-1055
[21.]
J.M. Perlman.
Intraventricular hemorrhage.
Pediatrics, 84 (1989), pp. 913-915
[22.]
M. Amitay, P.C. Etches, N.N. Finer, J.M. Maidens.
Synchronous mechanical ventilation of the neonate with respiratory disease.
Crit Care Med, 21 (1993), pp. 118-124
[23.]
A. Greenough, A.D. Milner, G. Dimitrou.
Syncronized mechanical for respiratory support in newborn infants.
Systematic Review, Issue 1,
[24.]
P. Davis, R. Jankov, L. Doyle, P.H. Henschke.
Randomised, controlled trial of nasal continuous positive airway pressure in the extubation of infants weighing 600-1200 gr.
Arch Dis Child Fetal Neonatal, 79 (1998), pp. F58
[25.]
The HIFO Study Group.
Randomised study of high frequency oscillatory ventilation in infants with severe respiratory distress syndrome.
J Pediatr, 122 (1993), pp. 609
[26.]
F. Morcillo, A. Gutiérrez, I. Izquierdo, J. Pérez, J. Quero, M.D. Elorza, et al.
Ventilación de alta frecuencia como estrategia de rescate en el recién nacido. Estudio multicéntrico español. I..
An Esp Pediatr, 50 (1999), pp. 269
[27.]
W.E. Truog.
High-frequency ventilation vs. conventional ventilation. No winner but no loser.
J Pediatr, 135 (1999), pp. 9-11
[28.]
D.J. Henderson-Smart, T. Bhuta, F. Cools, M. Offringa.
Effective high frequency oscillatory ventilation versus conventional ventilation for acute dysfunction pulmonary in preterm infants.
Systematic Review, Issue 1,
[29.]
F. Cools, M. Offringa.
Neuromuscular paralysis for newborn infants receiving mechanical ventilation.
Systematic Review, Issue 1,
[30.]
J.P. Kinsella, S.R. Neish, E. Shaffer, S.H. Abman.
Lowdose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.
Lancet, 340 (1992), pp. 819-820
[31.]
J.P. Kinsella, S.H. Abman.
Clinical approach to inhaled nitric oxide therapy in newborn with hipoxemia.
J Pediatr, 136 (2000), pp. 717-726
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos